Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

Finasteride may affect PNMT, causing side effects.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Finasteride's negative effects on brain tissue in male rats may be reversible after stopping the drug.

Sex hormones affect brain injury differently in males and females.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

DPP may help hair regrowth by improving blood vessel function under stress.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Ultrasound boosts finasteride's hair growth effects in mice.

Micro-needling with low-level light therapy effectively increases hair growth in people with mild to moderate hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Micro-CT helps identify suitable areas for surgical procedures based on blood vessel distribution in hypospadias-affected rats.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

DHT affects testicular development and regulates spermatogenesis in some fish.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Quercetin may help with PCOS symptoms, but more research is needed.

Finasteride is not expected to be effective for treating Acne vulgaris.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.